Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
Crossref DOI link: https://doi.org/10.1007/s40268-018-0234-z
Published Online: 2018-05-28
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buti, Sebastiano
Donini, Maddalena
Bersanelli, Melissa
Gattara, Alessia
Leonardi, Francesco
Passalacqua, Rodolfo
Text and Data Mining valid from 2018-05-28
Article History
First Online: 28 May 2018